2m 2m 2m 2m 2m 2m 2m
BONE BIO (BBLG)
NASDAQ
$0.39-$0.01 (-3.11%)
Price as of Oct 23, 2026 4:00 PM EDT- $1.1MMarket Cap
- -81.65%1-Year Change
- BiotechnologyIndustry
BONE BIO (BBLG)
$0.39-$0.01 (-3.11%)
BBLG | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.41 | ||
Change | -$0.01 (-3.43%) | ||
Open | $0.41 | ||
High | $0.42 | ||
Low | $0.39 | ||
Previous Close | $0.42 | ||
Volume | 25,137 | ||
30-Day Average Volume | 64,224 | ||
1-Week Change | 4.64% | ||
1-Month Change | -16.35% | ||
1-Year Change | -81.65% | ||
3-Year Change | -98.59% | ||
5-Year Change | -99.99% | ||
Fundamentals | |||
Shares Outstanding | 2.8M | ||
Total Assets | $4.4M | ||
Market Cap | $1.1M | ||
Enterprise Value | -$2.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$739,690.00 | ||
Free Cash Flow | -$518,440.00 | ||
EBIT | -$739,690.00 | ||
EBITDA | -$739,690.00 | ||
Net Working Capital | $3.9M | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | 4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | N/A | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/10/2025 | ||
Earnings & Revenue